Literature DB >> 24717230

Squamous cell carcinoma arising in association with verruca vulgares and HPV-2: a clinicopathologic study with p16 and p53 immunohistochemical studies and human papillomavirus in situ hybridization studies.

Steven M Ruhoy1, Donald G Guinee, Gerard Nuovo.   

Abstract

BACKGROUND: We observed cutaneous squamous cell carcinomas of the skin (SCCS) with histologic features suggesting they are arising in association with verruca vulgares (SCC-VV). We analyzed SCC-VV to determine what types of human papillomaviruses (HPVs) could be detected by in situ hybridization. We also analyzed demographic and clinical features and performed immunohistochemical studies for p53, p16, and Ki-67.
MATERIALS AND METHODS: Five cases of SCC-VV were chosen and compared with 5 cases each of cutaneous squamous cell carcinoma with bowenoid features (SCC-BD), and cutaneous squamous cell carcinoma with keratoacanthomatous features (SCC-KA).
RESULTS: We identified HPV-2 in 3 of 5 SCC-VV and SCC-KA, and 2 of 5 SCC-BD. SCC-VV showed a decreased amount of p16 immunoexpression compared with the other types, particularly SCC-BD (P=0.0108 ). SCC-KA showed a decreased p53 (P=0.0096) and Ki-67 (P=0.0007) immunoexpression compared with the other types.
CONCLUSIONS: SCC-VV seems to occur in older immunocompetent individuals and may be distinguishable from other SCCS types by histologic and immunohistochemical methods. HPV-2 and HPV-1 were the only types of HPV identified in this study, including SCCS with such diverse morphologic appearances as SCC-VV, SCC-BD, and SCC-KA. Further studies are needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24717230     DOI: 10.1097/PDM.0000000000000028

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  1 in total

1.  High-risk mucosal HPV types associated with squamous cell carcinoma on the nose tip in an immunocompetent young man.

Authors:  Camila Fátima Biancardi Gavioli; Cyro Festa Neto; Stephen K Tyring; Lana Luiza da Cruz Silva; Walmar Roncalli Pereira de Oliveira
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.